The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, ...
CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...
CRISPR Therapeutics' Casgevy, the first CRISPR/Cas9 gene editing therapy, shows promising results in treating Sickle Cell Disease and beta thalassemia but faces challenges in patient adoption and cost ...
CRISPR-Cas systems are the only known acquired immune systems in bacteria. They can store genetic information from attacking phages—viruses that infect bacteria—to combat future infections. In CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results